Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Addition of More Immunosuppressive Drugs As Graft-Versus-Host Disease (GVHD) Prophylaxis Does Not Improve Gvhd Outcomes in Reduced Intensity Allogeneic Hematopoietic Cell Transplantation from Unrelated Donors

Mauricette Michallet, MD PhD, Mohamad Sobh, PharmD, Fiorenza Barraco, MD, Xavier Thomas, MD PhD, Marie Balsat, MD, Caroline Lejeune, MD, Sophie Ducastelle, MD, Myriam Renault, CRA, Nathalie Tedone, CRA, Helene Labussiere, MD, Franck-Emmanuel Nicolini, MD PhD

Blood (2016) 128 (22): 5786.

https://doi.org/10.1182/blood.V128.22.5786.5786

Published: 2016

Journal Articles

HLA-DRB4 Mismatch Is Associated with Worse Outcomes in Unrelated Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies

Marie Y. Detrait, MD, Ibrahim Yakoub-Agha, MD, PhD, Valerie Dubois, MD, Françoise Dufossé, Myriam Labalette, Mohamad Sobh, Pharm.M., Stéphane Morisset, Stat., Nathalie Tedone, CRA, Sylvie Rey, Elodie Morais, Mauricette Michallet, MD, PhD

Blood (2012) 120 (21): 4540.

https://doi.org/10.1182/blood.V120.21.4540.4540

Published: 2012

Journal Articles

Flamsa-RIC Sequential Regimen in High Risk CR1 AML Patients: Preliminary Results From a Pilot Study

Blood (2012) 120 (21): 4549.

https://doi.org/10.1182/blood.V120.21.4549.4549

Published: 2012

Journal Articles

The Impact of Anti-HLA Antibodies on Allogeneic Hematopoietic Stem Cell Transplantation Outcomes After Reduced-Intensity Conditioning Regimens

Marie Y. Detrait, MD, Valerie Dubois, MD, Mohamad Sobh, Pharm.M., Stephane Morisset, Stat., Nathalie Tedone, CRA, Franck E. Nicolini, MD, PhD, Helene Labussiere, MD, Lilia Gillis, MD, Fiorenza Barraco, MD, Giovanna Cannas, MD, Sophie Ducastelle, MD, Jihane Fattoum, MD, PhD, Xavier Thomas, MD, PhD, Youcef Chelghoum, MD, Mauricette Michallet

Blood (2011) 118 (21): 2038.

https://doi.org/10.1182/blood.V118.21.2038.2038

Published: 2011

Journal Articles

Outcome of High-Risk and Refractory AML/MDS Patients Receiving a FLAMSA Sequential Chemotherapy Regimen Followed by Reduced-Intensity Conditioning (RIC) and Allogeneic Hematopoeitic Stem Cell Transplantation (allo-HSCT)

Marie Y. Detrait, MD, Patrice Chevallier, MD, PhD, Mohamad Sobh, Pharm.M., Thierry Guillaume, Xavier Thomas, MD, PhD, Stephane Morisset, Stat., Nathalie Tedone, CRA, Jacques Delaunay, MD, Franck E. Nicolini, MD, PhD, Helene Labussiere, MD, Sophie Ducastelle, MD, Jihane Fattoum, MD, PhD, Fiorenza Barraco, MD, Giovanna Cannas, MD, Youcef Chelghoum, MD, Mohamad Mohty, Mauricette Michallet

Blood (2011) 118 (21): 1957.

https://doi.org/10.1182/blood.V118.21.1957.1957

Published: 2011

Journal Articles

Highly Significant Impact of HLA-DRB3 and HLA-DRB4 Matching on Different Unrelated Allo-HSCT Outcomes: New Perspectives in the Unrelated Donor Selection

Marie Y. Detrait, MD, Valerie Dubois, MD, Mohamad Sobh, Pharm.M., Stephane Morisset, Stat., Franck E. Nicolini, MD, PhD, Helene Labussiere, MD, Fiorenza Barraco, MD, Giovanna Cannas, MD, Sophie Ducastelle, MD, Jihane Fattoum, MD, PhD, Xavier Thomas, MD, PhD, Youcef Chelghoum, MD, Nathalie Tedone, CRA, Sylvie Rey, Mauricette Michallet

Blood (2011) 118 (21): 4481.

https://doi.org/10.1182/blood.V118.21.4481.4481

Published: 2011

Journal Articles

Relapse After Allogeneic Hematopoietic Stem Cell Transplantation in Hematological Malignancies: Factors Impacting Its Occurrence and Treatment Options for a Better Management,

Mauricette Michallet, Mohamad Sobh, Pharm.M., Stephane Morisset, Stat., Helene Labussiere, MD, Marie Y. Detrait, MD, Sophie Ducastelle, MD, Fiorenza Barraco, MD, Jihane Fattoum, MD, PhD, Nathalie Tedone, CRA, Youcef Chelghoum, MD, Giovanna Cannas, MD, Xavier Thomas, MD, PhD, Franck E. Nicolini, MD, PhD

Blood (2011) 118 (21): 4093.

https://doi.org/10.1182/blood.V118.21.4093.4093

Published: 2011

Journal Articles

Double Cord Blood Units Allogeneic Transplantation for Hematological Malignancies: Study of the “3 Partners” Matching Variables on Transplant Outcomes

Mauricette Michallet, Mohamad Sobh, Pharm.M., Stephane Morisset, Stat., Helene Labussiere, MD, Marie Y. Detrait, MD, Franck E. Nicolini, MD, PhD, Sophie Ducastelle, MD, Fiorenza Barraco, MD, Xavier Thomas, MD, PhD, Nathalie Tedone, CRA, Youcef Chelghoum, MD, Jihane Fattoum, MD, PhD, Isabelle Mollet, Valerie Dubois, MD

Blood (2011) 118 (21): 3111.

https://doi.org/10.1182/blood.V118.21.3111.3111

Published: 2011

Journal Articles

Rituximab In Allogeneic Hematopoietic Stem Cell Transplantation for Advanced Chronic Lymphocytic Leukemia with Fludarabine + Total Body Irradiation Conditioning: Results of a Phase II Prospective Multicenter Study (ITAC 02-02)

Mauricette Michallet, Mohamad Sobh, Pharm.M., Stephane Morisset, Stat., Mohamad Mohty, Gerard Socie, Reza Tabrizi, Noel Milpied, MD, Pierre Bordigoni, MD, Nathalie Tedone, CRA, Jacques-Olivier Bay, MD, PhD, Didier Blaise, MD

Blood (2010) 116 (21): 3520.

https://doi.org/10.1182/blood.V116.21.3520.3520

Published: 2010

Journal Articles

Phase II Prospective Multicenter Study of Treosulfan Based Reduced Intensity Conditioning In Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies From 10/10 HLA Identical Unrelated Donor

Mauricette Michallet, MD, PhD, Mohamad Sobh, Pharm.M., Stephane Morisset, Stat., Nathalie Tedone, CRA, Jacques-Olivier Bay, MD, PhD, Jean-Luc Harousseau, MD, PhD, Mohamad Mohty, Ibrahim Yakoub-Agha, MD, PhD, Agnes Buzyn, MD, PhD, Noel Milpied, MD, Franck E Nicolini, MD, PhD, Helene Labussiere, MD, Joachim Baumgart, PhD, Nicole Raus, Reza Tabrizi, MD, Didier Blaise, MD

Blood (2010) 116 (21): 2353.

https://doi.org/10.1182/blood.V116.21.2353.2353

Published: 2010

Journal Articles

Faster Registration on International Donor Registries and Shorter Time to Allogeneic Hematopoietic Stem Cell Transplantation After Having Found a Donor Confers Better Outcome In Acute Leukemia Patients

Mauricette Michallet, Mohamad Sobh, Pharm.M., Stephane Morisset, Stat., Xavier Thomas, MD, PhD, Youcef Chelghoum, MD, Helene Labussiere, MD, Franck E Nicolini, MD, PhD, Sophie Ducastelle, MD, Fiorenza Barraco, MD, Nathalie Tedone, CRA, Jihane Fatoum, MD, Marie Detrait, MD, Sylvie Rey, Valerie Dubois, MD

Blood (2010) 116 (21): 2371.

https://doi.org/10.1182/blood.V116.21.2371.2371

Published: 2010

Journal Articles

HLA Matching Is More Critical Than CMV Matching in Predicting Non-Relapse-Mortality of Patients Undergoing HSCT From An Unrelated Donor: A Retrospective Monocenter Study.

Roberto Crocchiolo, MD, Sophie Ducastelle, MD, Hélène Labussière, MD, Franck Emmanuel Nicolini, MD, PhD, Xavier Thomas, MD, PhD, Fiorenza Barraco, MD, Giovanna Cannas, MD, Samia Madene, MD, Youcef Chelghoum, MD, Nathalie Tedone, Mohamad Sobh, Pharm.M, Mauricette Michallet, MD, PhD

Blood (2009) 114 (22): 4336.

https://doi.org/10.1182/blood.V114.22.4336.4336

Published: 2009

Journal Articles

Validation of Positive Effect of Posaconazole Prophylaxis During Induction Chemotherapy in AML: Study of Invasive Aspergillosis Incidence and of Risk Factors On Short and Long-Term Survival.

Mauricette Michallet, MD, PhD, Mohamad Sobh, Pharm.M, Stéphane Morisset, MSc, Giovanna Cannas, MD, Franck Emmanuel Nicolini, MD, PhD, Sophie Ducastelle, MD, Emmanuelle Nicolas-Virelizier, MD, Fiorenza Barraco, MD, Youcef Chelghoum, MD, Samira Kraghel, Nathalie Tedone, Mohamed El Hamri, PhD, Hélène Labussière, MD, Xavier Thomas, MD, PhD, Anne-Lise Bienvenu, Frédérique De Monbrison, Stéphane Picot, Marie-Christine Nicoll, Philippe Vanhems, MD

Blood (2009) 114 (22): 4124.

https://doi.org/10.1182/blood.V114.22.4124.4124

Published: 2009

Journal Articles

Allogeneic Hematopoietic Stem Transplantation Does Not Erase the Impact of the New Prognosis Classification in AML and the Negative Influence of Evi1 and Flt3 ITD Mutations.

Mauricette Michallet, MD, PhD, Mohamad Sobh, Pharm.M, Sandrine Hayette, MD, Carole Charlot, Mohamed El Hamri, PhD, Nathalie Tedone, Franck Emmanuel Nicolini, MD, PhD, Giovanna Cannas, MD, Youcef Chelghoum, MD, Emmanuelle Nicolas-Virelzier, MD, Sophie Ducastelle, MD, Fiorenza Baracco, MD, Isabelle Tigaud, MD, Xavier Thomas, MD, PhD

Blood (2009) 114 (22): 4678.

https://doi.org/10.1182/blood.V114.22.4678.4678

Published: 2009

Journal Articles

Standard and Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantations (HSCT) from Related and Unrelated Donors for Chronic Lymphocytic Leukemia (CLL). a Long-Term Follow-up (10 years) Study from the EBMT Registry. (CLL Sub-Committee on Behalf of EBMT CLWP)

Mauricette Michallet, MD, PhD, Quoc Hung Le, MD, Peter Dreger, Mohamad Sobh, PhD, Dietger Niederwieser, MD, Vladimir Koza, MD, Tapani Ruutu, Nigel H. Russell, MD, Leo Verdonck, Donald Milligan, MD, MBChB, Nathalie Dhedin, Tomas Kozak, MD, PhD, Marc Boogaerts, MD, PhD, Juergen Finke, Nathalie Tedone, Anja Van Biezen, Ronald Brand, Theo de Witte on behalfhe European Group for Blood Marrow Transplantation

Blood (2008) 112 (11): 566.

https://doi.org/10.1182/blood.V112.11.566.566

Published: 2008

NARROW

Addition of More Immunosuppressive Drugs As Graft-Versus-Host Disease (GVHD) Prophylaxis Does Not Improve Gvhd Outcomes in Reduced Intensity Allogeneic Hematopoietic Cell Transplantation from Unrelated Donors

HLA-DRB4 Mismatch Is Associated with Worse Outcomes in Unrelated Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies

Flamsa-RIC Sequential Regimen in High Risk CR1 AML Patients: Preliminary Results From a Pilot Study

The Impact of Anti-HLA Antibodies on Allogeneic Hematopoietic Stem Cell Transplantation Outcomes After Reduced-Intensity Conditioning Regimens

Outcome of High-Risk and Refractory AML/MDS Patients Receiving a FLAMSA Sequential Chemotherapy Regimen Followed by Reduced-Intensity Conditioning (RIC) and Allogeneic Hematopoeitic Stem Cell Transplantation (allo-HSCT)

Highly Significant Impact of HLA-DRB3 and HLA-DRB4 Matching on Different Unrelated Allo-HSCT Outcomes: New Perspectives in the Unrelated Donor Selection

Relapse After Allogeneic Hematopoietic Stem Cell Transplantation in Hematological Malignancies: Factors Impacting Its Occurrence and Treatment Options for a Better Management,

Double Cord Blood Units Allogeneic Transplantation for Hematological Malignancies: Study of the “3 Partners” Matching Variables on Transplant Outcomes

Rituximab In Allogeneic Hematopoietic Stem Cell Transplantation for Advanced Chronic Lymphocytic Leukemia with Fludarabine + Total Body Irradiation Conditioning: Results of a Phase II Prospective Multicenter Study (ITAC 02-02)

Phase II Prospective Multicenter Study of Treosulfan Based Reduced Intensity Conditioning In Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies From 10/10 HLA Identical Unrelated Donor

Faster Registration on International Donor Registries and Shorter Time to Allogeneic Hematopoietic Stem Cell Transplantation After Having Found a Donor Confers Better Outcome In Acute Leukemia Patients

HLA Matching Is More Critical Than CMV Matching in Predicting Non-Relapse-Mortality of Patients Undergoing HSCT From An Unrelated Donor: A Retrospective Monocenter Study.

Validation of Positive Effect of Posaconazole Prophylaxis During Induction Chemotherapy in AML: Study of Invasive Aspergillosis Incidence and of Risk Factors On Short and Long-Term Survival.

Allogeneic Hematopoietic Stem Transplantation Does Not Erase the Impact of the New Prognosis Classification in AML and the Negative Influence of Evi1 and Flt3 ITD Mutations.

Standard and Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantations (HSCT) from Related and Unrelated Donors for Chronic Lymphocytic Leukemia (CLL). a Long-Term Follow-up (10 years) Study from the EBMT Registry. (CLL Sub-Committee on Behalf of EBMT CLWP)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only